期刊文献+

经内镜逆行胰胆管造影术后患者并发胰腺炎的危险因素分析及预防措施 被引量:3

Analysis of risk factors and preventive measures related to pancreatitis in patients after endoscopic retrograde cholangiopancreatography
下载PDF
导出
摘要 目的探讨经内镜逆行胰胆管造影(ERCP)术后患者并发胰腺炎的危险因素与预防措施。方法选择2018年6月至2019年6月我院150例ERCP患者为研究对象,调查术后胰腺炎发生情况,采用多因素logistic回归分析调查ERCP术后患者并发胰腺炎的危险因素。结果150例ERCP患者术后并发胰腺炎12例。多因素logistic回归分析显示,插管困难、胰管显影、十二指肠憩室是ERCP术后并发胰腺炎的独立危险因素(P<0.05),鼻胆管引流是ERCP术后并发胰腺炎的保护因素(P<0.05)。结论插管困难、胰管显影、十二指肠憩室会增加ERCP术后患者并发胰腺炎风险,可采取相应护理措施进行预防。 Objective To explore the risk factors and preventive measures related to pancreatitis in patients after endoscopic retrograde cholangiopancreatography(ERCP).Methods To select 150 cases of ERCP patients in our hospital from June 2018 to June 2019 as the study objects and investigate the occurrence of postoperative pancreatitis.Multivariate logistic regression analysis was used to investigate the risk factors of pancreatitis in patients after ERCP.Results There were 12 cases of postoperative pancreatitis in 150 cases of patients with ERCP.Multivariate logistic regression analysis showed that the difficulty intubation,pancreatic duct imaging and duodenal diverticulum were the independent risk factors for pancreatitis after ERCP(P<0.05),while nasobiliary duct drainage was a protective factor for pancreatitis after ERCP(P<0.05).Conclusion Difficulty intubation,pancreatic duct imaging and duodenal diverticulum will increase the risk of pancreatitis in patients after ERCP,so corresponding nursing measures can be taken to prevent it.
作者 蒿玉敬 胡春霞 曹桂莉 HAO Yu-jing;HU Chun-xia;CAO Gui-li
出处 《护理实践与研究》 2020年第16期21-23,共3页 Nursing Practice and Research
关键词 ERCP术 胰腺炎 危险因素 预防措施 Endoscopic retrograde cholangiopancreatography Pancreatitis Risk factors Preventive measures
  • 相关文献

参考文献15

二级参考文献129

  • 1荣亮,侯慧,郑森元,李可.吲哚美辛预防经内镜逆行胰胆管造影术后胰腺炎和高淀粉酶血症的效果[J].中国老年学杂志,2014,34(7):1807-1809. 被引量:5
  • 2黄志强.新世纪的胆道外科[J].临床外科杂志,2004,12(1):12-14. 被引量:54
  • 3闫波,赵建妹,沈云志,孙克文,秦怡.ERCP术后胰腺炎的影响因素分析[J].胰腺病学,2007,7(3):178-180. 被引量:10
  • 4LI X, MENG W, ZHANG L, et al. Risk factors for postendo- scopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases [ J ]. Pancreatology, 2011 , 11 (3) : 399 -405.
  • 5TUENNEMANN J, MOSSNER J, BEER S. Acute pancreati- tis. guideline - based diagnosis and treatment [ J ]. Internist ( Berl), 2014, 55(9) : 1045 -1056.
  • 6SHAH TU, LIDDLE R, BRANCH MS, et al. Pilot study of aprepi- tant for pr evention of post -ERCP pancreatitis in high risk pa- tients: a phase Ⅱ randomized,double -blind placebo controlled trial[J]. JOP, 2012, 13(2) : 514 -518.
  • 7WANG P, LI ZS, LIU F, et al. Risk factors for ERCP -related complications: a prospective multicenter study[ J]. Am J Gastroenterol, 2009, 104(7): 31 -40.
  • 8TSUJINO T, KOMATSU Y, ISAYAMA H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatog- raphy: a randomized, controlled trial [ J ]. Clin Gastroenterol Hepatol, 2005, 3(1): 376-383.
  • 9ELMUNZER B J, SCHEIMAN JM, LEHMAN GA, et al. A ran- domized trial of rectal indomethacin to prevent post - ERCP pancreatitis[J]. N Engl J Med, 2012, 366(11): 1414- 1422.
  • 10KOBAYASHI Y, KANEMITU T, KAMOTO A, et al. Painless acute pancreatitis associated with sorafenib treatment; a case report[J]. Med Oncol, 2011, 28(3): 463 -465.

共引文献214

同被引文献29

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部